학술논문
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1740634X